Wealthfront Advisers
BIIB icon

Wealthfront Advisers’s Biogen BIIB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.09M Buy
8,684
+4,899
+129% +$615K ﹤0.01% 664
2025
Q1
$518K Buy
3,785
+1,949
+106% +$267K ﹤0.01% 773
2024
Q4
$281K Sell
1,836
-1,316
-42% -$201K ﹤0.01% 844
2024
Q3
$611K Sell
3,152
-371
-11% -$71.9K ﹤0.01% 736
2024
Q2
$817K Sell
3,523
-2,138
-38% -$496K ﹤0.01% 662
2024
Q1
$1.22M Sell
5,661
-271
-5% -$58.4K ﹤0.01% 576
2023
Q4
$1.54M Buy
5,932
+332
+6% +$85.9K 0.01% 512
2023
Q3
$1.44M Sell
5,600
-4,941
-47% -$1.27M 0.01% 488
2023
Q2
$3M Buy
10,541
+205
+2% +$58.4K 0.01% 325
2023
Q1
$2.87M Buy
10,336
+3,825
+59% +$1.06M 0.01% 331
2022
Q4
$1.8M Buy
6,511
+133
+2% +$36.8K 0.01% 427
2022
Q3
$1.7M Buy
6,378
+1,869
+41% +$499K 0.01% 397
2022
Q2
$920K Sell
4,509
-5,526
-55% -$1.13M ﹤0.01% 499
2022
Q1
$2.11M Buy
10,035
+7,508
+297% +$1.58M 0.01% 387
2021
Q4
$606K Sell
2,527
-8,077
-76% -$1.94M ﹤0.01% 565
2021
Q3
$3M Sell
10,604
-169
-2% -$47.8K 0.01% 253
2021
Q2
$3.73M Buy
10,773
+1,572
+17% +$544K 0.02% 172
2021
Q1
$2.57M Buy
9,201
+2,872
+45% +$803K 0.01% 213
2020
Q4
$1.55M Buy
6,329
+550
+10% +$135K 0.01% 286
2020
Q3
$1.64M Sell
5,779
-2,154
-27% -$611K 0.01% 222
2020
Q2
$2.12M Sell
7,933
-1,974
-20% -$528K 0.02% 156
2020
Q1
$3.13M Buy
9,907
+1,265
+15% +$400K 0.03% 95
2019
Q4
$2.56M Buy
8,642
+3,986
+86% +$1.18M 0.02% 136
2019
Q3
$1.08M Buy
4,656
+201
+5% +$46.8K 0.01% 278
2019
Q2
$1.04M Buy
4,455
+2,658
+148% +$622K 0.01% 267
2019
Q1
$425K Sell
1,797
-7,201
-80% -$1.7M ﹤0.01% 382
2018
Q4
$2.71M Buy
+8,998
New +$2.71M 0.03% 100